Advancing neurological therapies with Dr Bruce Leuchter
Drug Target Review
FEBRUARY 1, 2024
What challenges has the industry faced in developing and commercialising treatments for neurological diseases, including rare diseases? But commitment to neuroscience drug development is critically important given the significant unmet medical needs and the ways in which patients, caregivers, and families suffer.
Let's personalize your content